Abstract

Mitochondrial diseases are a heterogeneous group of diseases resulting from energy deficit and reduced adenosine triphosphate (ATP) production due to impaired oxidative phosphorylation. The manifestation of mitochondrial disease is usually multi-organ. Epilepsy is one of the most common manifestations of diseases resulting from mitochondrial dysfunction, especially in children. The onset of epilepsy is associated with poor prognosis, while its treatment is very challenging, which further adversely affects the course of these disorders. Fortunately, our knowledge of mitochondrial diseases is still growing, which gives hope for patients to improve their condition in the future. The paper presents the pathophysiology, clinical picture and treatment options for epilepsy in patients with mitochondrial disease.

Highlights

  • Mitochondria are organelles that are present in almost all cells of the body, which are primarily responsible for producing energy by the process of oxidative phosphorylation (OXPHOS), play a role in the homeostasis of calcium ions, take part in signal transduction between cells by producing reactive oxygen species, and participate in cell apoptosis [1,2]

  • Pathophysiology of Epilepsy in Mitochondrial Diseases Epileptic seizure is a sudden and excessive neural discharge resulting from uncontrolled depolarisation of the neural membrane, and its spread is caused by impaired mechanisms regulating this transmission, e.g., balance between inhibitory

  • Most interventions and guidelines are related to symptomatic treatment, with supplementation of cofactors, vitamins, or antioxidants, and mild exercises are recommended

Read more

Summary

Introduction

Mitochondria are organelles that are present in almost all cells of the body, which are primarily responsible for producing energy (in the form of ATP) by the process of oxidative phosphorylation (OXPHOS), play a role in the homeostasis of calcium ions, take part in signal transduction between cells by producing reactive oxygen species, and participate in cell apoptosis [1,2]. The diseases may result both from a pathogenic variant in all 37 genes of mitochondrial DNA (mtDNA) and damage to nuclear DNA (nDNA). 2. Pathophysiology of Epilepsy in Mitochondrial Diseases Epileptic seizure is a sudden and excessive neural discharge resulting from uncontrolled depolarisation of the neural membrane, and its spread is caused by impaired mechanisms regulating this transmission, e.g., balance between inhibitory 2. Pathophysiology of Epilepsy in Mitochondrial Diseases Epileptic seizure is a sudden and excessive neural discharge resulting from un2coof n11-. Typical features include: (1) developmental regression or developmental delay, (2) specific basal ganglia/brain stem changes bilaterally, and (3) abnormal mitochondrial energy metabolism; epileptic seizures are frequent, both focal and generalised. L-arginine and/or citrulline as prevention and treatment of stroke-like episodes

Clinical Picture of Epilepsy in Mitochondrial Diseases
Neuroimaging
Pharmacological Treatment of Epilepsy in Patients with Mitochondrial Disease
Findings
Conclusions

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.